With the continued use of COVID-19 vaccines worldwide, there’s a massive amount of data that shows mRNA shots are safe.

Special Report: Lumos Diagnostics has passed a major milestone in a US CLIA waiver study for its rapid point-of-care diagnostic FebriDx designed to differentiate between bacterial and non-bacterial ...

US tensions with two key trade partners amped up on Monday after President Trump doubled tariffs on steel and aluminum and ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

The Global Single-use Assemblies Market valued at $2.25 billion (2021) is set to witness a healthy growth rate of 22% by 2026. Key advantages of ready-to-use single-use assemblies, favorable funding ...

The Global Sepsis Diagnostics Market valued at ~$510 million (2021) is set to witness a healthy growth rate of 9% in the next 5 years. Development of rapid diagnostic tests/point-of-care techniques, ...

Pharma’s sharply declining COVID-19 market is now grappling with a controversial new policy shift. Last week, HHS Secretary ...